What Researchers Did
Researchers reviewed the records of 46 patients treated with hyperbaric oxygen therapy for bone damage (osteoradionecrosis) in the jaw and head and neck area after radiation therapy, looking for factors linked to whether the condition improved or got worse.
What They Found
This retrospective study of 46 patients found that osteoradionecrosis regressed or stabilized in 36 patients, while it worsened in 10 patients. The condition affected the mandible (lower jaw) in 93.5% of cases, the maxilla (upper jaw) in 2 cases, and the base of the skull in 4 cases. All patients received HBOT, averaging 44.65 sessions overall, with treatment given before surgery in 17% of cases and after surgery in 42% of cases. In a separate analysis of patients who completed at least 20 sessions, the condition regressed in 33%, stabilized in 45%, and worsened in 22%. Statistical testing linked disease progression to high blood pressure (p equals 0.046), larger tumor size (p equals 0.004), advanced tumor stage (p equals 0.048), higher radiation dose (p equals 0.002), longer delay between dental care and radiotherapy (p equals 0.045), and ORN location within the mandible (p equals 0.049). A higher number of HBOT sessions was associated with better outcomes (p equals 0.001), and the interval between dental care and radiotherapy remained significant in multivariate analysis (p equals 0.043).
What This Means for Canadian Patients
For patients receiving HBOT for radiation-related jaw or head and neck bone damage, this study suggests that completing more treatment sessions was associated with better outcomes in this patient group, though the retrospective design cannot prove that more sessions directly caused the improvement. Several patient and treatment factors showed statistical links to how the condition progressed, but the study does not establish that changing monitoring or treatment based on these factors improves results.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a retrospective, observational study with a small subgroup of worsening cases (10 patients), so it can identify associations but cannot establish that any single factor, including number of HBOT sessions, causes better or worse outcomes.